{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:01:10Z","timestamp":1793995270599,"version":"4.8.0"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82271294"],"award-info":[{"award-number":["Grant No. 82271294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82470923"],"award-info":[{"award-number":["Grant No. 82470923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Liaoning Province","award":["Grant No. 2021-MS-201"],"award-info":[{"award-number":["Grant No. 2021-MS-201"]}]},{"name":"the Basic Scientific Research Projects of Liaoning Provincial Department of Education","award":["Grant No. LJKMZ20221178"],"award-info":[{"award-number":["Grant No. LJKMZ20221178"]}]},{"name":"the Basic Scientific Research Projects of Liaoning Provincial Department of Education","award":["Grant No. LJKMZ20221164"],"award-info":[{"award-number":["Grant No. LJKMZ20221164"]}]},{"name":"the 345 Talent Project of Shengjing Hospital of China Medical University"},{"name":"the Applied Basic Research Program of Liaoning Province","award":["Grant No. 2022JH2\/101500050"],"award-info":[{"award-number":["Grant No. 2022JH2\/101500050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09046-1","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:42:30Z","timestamp":1744278150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis"],"prefix":"10.1007","volume":"68","author":[{"given":"Zeyao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-6427","authenticated-orcid":false,"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"9046_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","volume":"19","author":"I Foessl","year":"2023","unstructured":"Foessl I, Dimai HP, Obermayer-Pietsch B (2023) Long-term and sequential treatment for osteoporosis. Nat Rev Endocrinol 19:520\u2013533","journal-title":"Nat Rev Endocrinol"},{"key":"9046_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms241914583","volume":"24","author":"B Adejuyigbe","year":"2023","unstructured":"Adejuyigbe B, Kallini J, Chiou D, Kallini JR (2023) Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci 24:18","journal-title":"Int J Mol Sci"},{"key":"9046_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","volume":"43","author":"PR Ebeling","year":"2022","unstructured":"Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F (2022) Secondary osteoporosis. Endocr Rev 43:240\u2013313","journal-title":"Endocr Rev"},{"key":"9046_CR4","first-page":"17","volume":"15","author":"YJ Chen","year":"2024","unstructured":"Chen YJ, Jia LH, Han TH et al (2024) Osteoporosis treatment: current drugs and future developments. Front Pharmacol 15:17","journal-title":"Front Pharmacol"},{"key":"9046_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms21207623","volume":"21","author":"JY Noh","year":"2020","unstructured":"Noh JY, Yang Y, Jung H (2020) Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci 21:22","journal-title":"Int J Mol Sci"},{"key":"9046_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki M, Takayanagi H (2019) Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol 19:626\u2013642","journal-title":"Nat Rev Immunol"},{"key":"9046_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/ar3375","volume":"13","author":"P Geusens","year":"2011","unstructured":"Geusens P, Lems WF (2011) Osteoimmunology and osteoporosis. Arthritis Res Ther 13:16","journal-title":"Arthritis Res Ther"},{"key":"9046_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/35046196","volume":"408","author":"JR Arron","year":"2000","unstructured":"Arron JR, Choi Y (2000) Osteoimmunology - bone versus immune system. Nature 408:535\u2013536","journal-title":"Nature"},{"key":"9046_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","volume":"5","author":"H Takayanagi","year":"2009","unstructured":"Takayanagi H (2009) Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 5:667\u2013676","journal-title":"Nat Rev Rheumatol"},{"key":"9046_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1101\/cshperspect.a031245","volume":"9","author":"K Okamoto","year":"2019","unstructured":"Okamoto K, Takayanagi H (2019) Osteoimmunology. Cold Spring Harb Perspect Med 9:28","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9046_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2020.00058","volume":"11","author":"C Guder","year":"2020","unstructured":"Guder C, Gravius S, Burger C, Wirtz DC, Schildberg FA (2020) Osteoimmunology: a current update of the interplay between bone and the immune system. Front Immunol 11:19","journal-title":"Front Immunol"},{"key":"9046_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2021.687037","volume":"12","author":"Y Saxena","year":"2021","unstructured":"Saxena Y, Routh S, Mukhopadhaya A (2021) Immunoporosis: role of innate immune cells in osteoporosis. Front Immunol 12:19","journal-title":"Front Immunol"},{"key":"9046_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2018.00657","volume":"9","author":"RK Srivastava","year":"2018","unstructured":"Srivastava RK, Dar HY, Mishra PK (2018) Immunoporosis: immunology of osteoporosis-role of T cells. Front Immunol 9:12","journal-title":"Front Immunol"},{"key":"9046_CR14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2147\/JIR.S351918","volume":"15","author":"RK Srivastava","year":"2022","unstructured":"Srivastava RK, Sapra L (2022) The rising era of \u201cimmunoporosis\u201d: role of immune system in the pathophysiology of osteoporosis. J Inflamm Res 15:1667\u20131698","journal-title":"J Inflamm Res"},{"key":"9046_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/ni1101","volume":"5","author":"BA Schwarz","year":"2004","unstructured":"Schwarz BA, Bhandoola A (2004) Circulating hematopoietic progenitors with T lineage potential. Nat Immunol 5:953\u2013960","journal-title":"Nat Immunol"},{"key":"9046_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-023-01334-6","volume":"8","author":"LA Sun","year":"2023","unstructured":"Sun LA, Su YH, Jiao AJ, Wang X, Zhang BJ (2023) T cells in health and disease. Signal Transduct Target Ther 8:50","journal-title":"Signal Transduct Target Ther"},{"key":"9046_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fimmu.2019.00679","volume":"10","author":"F Coury","year":"2019","unstructured":"Coury F, Peyruchaud O, Machuca-Gayet I (2019) Osteoimmunology of bone loss in inflammatory rheumatic diseases. Front Immunol 10:9","journal-title":"Front Immunol"},{"key":"9046_CR18","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/jcmm.17399","volume":"26","author":"F Huang","year":"2022","unstructured":"Huang F, Wong P, Li JL et al (2022) Osteoimmunology: the correlation between osteoclasts and the Th17\/Treg balance in osteoporosis. J Cell Mol Med 26:3591\u20133597","journal-title":"J Cell Mol Med"},{"key":"9046_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C et al (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-\u03b1. J Clin Invest 106:1229\u20131237","journal-title":"J Clin Invest"},{"key":"9046_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1073\/pnas.1013492108","volume":"108","author":"JY Li","year":"2011","unstructured":"Li JY, Tawfeek H, Bedi B et al (2011) Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A 108:768\u2013773","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR21","doi-asserted-by":"publisher","first-page":"13960","DOI":"10.1073\/pnas.251534698","volume":"98","author":"C Roggia","year":"2001","unstructured":"Roggia C, Gao YH, Cenci S et al (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 98:13960\u201313965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR22","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/art.23138","volume":"56","author":"MM Zaiss","year":"2007","unstructured":"Zaiss MM, Axmann R, Zwerina J et al (2007) Treg cells suppress osteoclast formation -: a new link between the immune system and bone. Arthritis Rheum 56:4104\u20134112","journal-title":"Arthritis Rheum"},{"key":"9046_CR23","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.2147\/JIR.S367214","volume":"15","author":"CJ Chen","year":"2022","unstructured":"Chen CJ, Zhao X, Luo Y et al (2022) Imbalanced T-cell subsets may facilitate the occurrence of osteonecrosis of the femoral head. J Inflamm Res 15:4159\u20134169","journal-title":"J Inflamm Res"},{"key":"9046_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/eji.202350381","volume":"54","author":"ZX Wu","year":"2024","unstructured":"Wu ZX, Lin XX, Yuan GX, Li N, Xu R (2024) Innate lymphoid cells: new players in osteoimmunology. Eur J Immunol 54:7","journal-title":"Eur J Immunol"},{"key":"9046_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.14348\/molcells.2021.0053","volume":"44","author":"J Kim","year":"2021","unstructured":"Kim J, Ryu S, Kim HY (2021) Innate lymphoid cells in tissue homeostasis and disease pathogenesis. Mol Cells 44:301\u2013309","journal-title":"Mol Cells"},{"key":"9046_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00011-021-01504-8","volume":"70","author":"A Fathollahi","year":"2021","unstructured":"Fathollahi A, Samimi LN, Akhlaghi M, Jamshidi A, Mahmoudi M, Farhadi E (2021) The role of NK cells in rheumatoid arthritis. Inflamm Res 70:1063\u20131073","journal-title":"Inflamm Res"},{"key":"9046_CR27","doi-asserted-by":"publisher","first-page":"1220 -+","DOI":"10.1016\/j.immuni.2018.04.009","volume":"48","author":"K Hirota","year":"2018","unstructured":"Hirota K, Hashimoto M, Ito Y et al (2018) Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis. Immunity 48:1220-+","journal-title":"Immunity"},{"key":"9046_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/intimm\/dxab062","volume":"33","author":"Y Momiuchi","year":"2021","unstructured":"Momiuchi Y, Motomura Y, Suga E et al (2021) Group 2 innate lymphoid cells in bone marrow regulate osteoclastogenesis in a reciprocal manner via RANKL, GM-CSF and IL-13. Int Immunol 33:573\u2013585","journal-title":"Int Immunol"},{"key":"9046_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bone.2020.115335","volume":"136","author":"Y Omata","year":"2020","unstructured":"Omata Y, Frech M, Lucas S et al (2020) Type 2 innate lymphoid cells inhibit the differentiation of osteoclasts and protect from ovariectomy-induced bone loss. Bone 136:9","journal-title":"Bone"},{"key":"9046_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-019-1984-x","volume":"21","author":"A Takaki-Kuwahara","year":"2019","unstructured":"Takaki-Kuwahara A, Arinobu Y, Miyawaki K et al (2019) CCR6+group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Res Ther 21:9","journal-title":"Arthritis Res Ther"},{"key":"9046_CR31","first-page":"14","volume":"13","author":"WD Zhang","year":"2022","unstructured":"Zhang WD, Gao RH, Rong X et al (2022) Immunoporosis: role of immune system in the pathophysiology of different types of osteoporosis. Front Endocrinol 13:14","journal-title":"Front Endocrinol"},{"key":"9046_CR32","first-page":"30","volume":"25","author":"M Yang","year":"2024","unstructured":"Yang M, Zhu L (2024) Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis. Int J Mol Sci 25:30","journal-title":"Int J Mol Sci"},{"key":"9046_CR33","first-page":"22","volume":"15","author":"SY Li","year":"2024","unstructured":"Li SY, Liu G, Hu SW (2024) Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology. Front Immunol 15:22","journal-title":"Front Immunol"},{"key":"9046_CR34","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1074\/jbc.M510160200","volume":"281","author":"P Palmqvist","year":"2006","unstructured":"Palmqvist P, Lundberg P, Persson E et al (2006) Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. J Biol Chem 281:2414\u20132429","journal-title":"J Biol Chem"},{"key":"9046_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/ar2502","volume":"10","author":"IE Adamopoulos","year":"2008","unstructured":"Adamopoulos IE, Bowman EP (2008) Immune regulation of bone loss by Th17 cells. Arthritis Res Ther 10:9","journal-title":"Arthritis Res Ther"},{"key":"9046_CR36","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","volume":"75","author":"L Danks","year":"2016","unstructured":"Danks L, Komatsu N, Guerrini MM et al (2016) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75:1187\u20131195","journal-title":"Ann Rheum Dis"},{"key":"9046_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11914-017-0356-1","volume":"15","author":"A Bozec","year":"2017","unstructured":"Bozec A, Zaiss MM (2017) T Regulatory cells in bone remodelling. Curr Osteoporos Rep 15:121\u2013125","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11914-024-00869-z","volume":"22","author":"KH Molitoris","year":"2024","unstructured":"Molitoris KH, Huang MJ, Baht GS (2024) Osteoimmunology of fracture healing. Curr Osteoporos Rep 22:330\u2013339","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos IE, Chao CC, Geissler R et al (2010) Interleukin-17A upregulates receptor activator of NF-\u03baB on osteoclast precursors. Arthritis Res Ther 12:11","journal-title":"Arthritis Res Ther"},{"key":"9046_CR40","first-page":"866","volume":"123","author":"J Kikuta","year":"2013","unstructured":"Kikuta J, Wada Y, Kowada T et al (2013) Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest 123:866\u2013873","journal-title":"J Clin Invest"},{"key":"9046_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2019.02925","volume":"10","author":"A Marahleh","year":"2019","unstructured":"Marahleh A, Kitaura H, Ohori F et al (2019) TNF-\u03b1 directly enhances osteocyte RANKL expression and promotes osteoclast formation. Front Immunol 10:12","journal-title":"Front Immunol"},{"key":"9046_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fimmu.2014.00048","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta B, Benedetti G, Miossec P (2014) Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis. Front Immunol 5:9","journal-title":"Front Immunol"},{"key":"9046_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1073\/pnas.0136772100","volume":"100","author":"G Toraldo","year":"2003","unstructured":"Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN (2003) IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor \u03baB ligand and tumor necrosis factor a from T cells. Proc Natl Acad Sci U S A 100:125\u2013130","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3. Nature 408:600\u2013605","journal-title":"Nature"},{"key":"9046_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4049\/jimmunol.175.2.917","volume":"175","author":"LS Mangashetti","year":"2005","unstructured":"Mangashetti LS, Khapli SM, Wani MR (2005) IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-\u03baB and Ca2+ signaling. J Immunol 175:917\u2013925","journal-title":"J Immunol"},{"key":"9046_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellsig.2022.110353","volume":"95","author":"XR Gao","year":"2022","unstructured":"Gao XR, Ge J, Zhou WC, Xu L, Geng DQ (2022) IL-10 inhibits osteoclast differentiation and osteolysis through MEG3\/IRF8 pathway. Cell Signal 95:10","journal-title":"Cell Signal"},{"key":"9046_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2018.01417","volume":"9","author":"MZ Peng","year":"2018","unstructured":"Peng MZ, Wang YG, Qiang L et al (2018) Interleukin-35 inhibits TNF-\u03b1-induced osteoclastogenesis and promotes apoptosis via shifting the activation from TNF receptor-associated death domain (TRADD)-TRAF2 to TRADD-Fas-associated death domain by JAK1\/STAT1. Front Immunol 9:18","journal-title":"Front Immunol"},{"key":"9046_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cmi.2010.54","volume":"8","author":"CY Luo","year":"2011","unstructured":"Luo CY, Wang L, Sun C, Li DJ (2011) Estrogen enhances the functions of CD4+ CD25+ Foxp3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol 8:50\u201358","journal-title":"Cell Mol Immunol"},{"key":"9046_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI143137","volume":"131","author":"MC Yu","year":"2021","unstructured":"Yu MC, Pal S, Paterson CW et al (2021) Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF + T cells and Th17 cells. J Clin Invest 131:13","journal-title":"J Clin Invest"},{"key":"9046_CR50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41419-020-03341-9","volume":"12","author":"L Song","year":"2021","unstructured":"Song L, Cao LJ, Liu R et al (2021) The critical role of T cells in glucocorticoid-induced osteoporosis. Cell Death Dis 12:13","journal-title":"Cell Death Dis"},{"key":"9046_CR51","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/gutjnl-2014-306947","volume":"64","author":"T Ciucci","year":"2015","unstructured":"Ciucci T, Ib\u00e1\u00f1ez L, Boucoiran A et al (2015) Bone marrow Th17 TNF\u03b1 cells induce osteoclast differentiation, and link bone destruction to IBD. Gut 64:1072\u20131081","journal-title":"Gut"},{"key":"9046_CR52","doi-asserted-by":"publisher","first-page":"18525","DOI":"10.1073\/pnas.1302829110","volume":"110","author":"AJ Glowacki","year":"2013","unstructured":"Glowacki AJ, Yoshizawa S, Jhunjhunwala S et al (2013) Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci U S A 110:18525\u201318530","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175\u2013179","journal-title":"Nature"},{"key":"9046_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono T, Hayashi M, Sasaki F, Nakashima T (2020) RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen 40:16","journal-title":"Inflamm Regen"},{"key":"9046_CR55","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1210\/endo.141.12.7840","volume":"141","author":"F Gori","year":"2000","unstructured":"Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL (2000) The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141:4768\u20134776","journal-title":"Endocrinology"},{"key":"9046_CR56","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055","journal-title":"Endocrinology"},{"key":"9046_CR57","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345\u20131352","journal-title":"J Clin Invest"},{"key":"9046_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","volume":"253","author":"N Nakagawa","year":"1998","unstructured":"Nakagawa N, Kinosaki M, Yamaguchi K et al (1998) RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253:395\u2013400","journal-title":"Biochem Biophys Res Commun"},{"key":"9046_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"9046_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","volume":"265","author":"NJ Horwood","year":"1999","unstructured":"Horwood NJ, Kartsogiannis V, Quinn JMW, Romas E, Martin TJ, Gillespie MT (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144\u2013150","journal-title":"Biochem Biophys Res Commun"},{"key":"9046_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1359\/jbmr.2001.16.2.328","volume":"16","author":"MN Weitzmann","year":"2001","unstructured":"Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R (2001) T cell activation induces human osteoclast formation via receptor activator of nuclear factor \u03baB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328\u2013337","journal-title":"J Bone Miner Res"},{"key":"9046_CR62","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s00018-018-2817-9","volume":"75","author":"KH Park-Min","year":"2018","unstructured":"Park-Min KH (2018) Mechanisms involved in normal and pathological osteoclastogenesis. Cell Mol Life Sci 75:2519\u20132528","journal-title":"Cell Mol Life Sci"},{"key":"9046_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2014.00511","volume":"5","author":"MC Walsh","year":"2014","unstructured":"Walsh MC, Choi Y (2014) Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol 5:11","journal-title":"Front Immunol"},{"key":"9046_CR64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature02444","volume":"428","author":"T Koga","year":"2004","unstructured":"Koga T, Inui M, Inoue K et al (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758\u2013763","journal-title":"Nature"},{"key":"9046_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","volume":"83","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi H (2005) Mechanistic insight into osteoclast differentiation in osteolmmunology. J Mol Med 83:170\u2013179","journal-title":"J Mol Med"},{"key":"9046_CR66","first-page":"16","volume":"13","author":"B Li","year":"2022","unstructured":"Li B, Wang PR, Jiao J, Wei HF, Xu W, Zhou PT (2022) Roles of the RANKL-RANK axis in immunity-implications for pathogenesis and treatment of bone metastasis. Front Immunol 13:16","journal-title":"Front Immunol"},{"key":"9046_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.gendis.2020.03.009","volume":"8","author":"B Wang","year":"2021","unstructured":"Wang B, Dong YT, Tian ZS, Chen YQ, Dong SW (2021) The role of dendritic cells derived osteoclasts in bone destruction diseases. Genes Dis 8:401\u2013411","journal-title":"Genes Dis"},{"key":"9046_CR68","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","volume":"19","author":"AJ Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Cruickshank SM, Croucher PL et al (2003) Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 19:849\u2013861","journal-title":"Immunity"},{"key":"9046_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biopha.2022.113341","volume":"153","author":"HY Chen","year":"2022","unstructured":"Chen HY, Wang JM, Zhang CY et al (2022) Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases. Biomed Pharmacother 153:10","journal-title":"Biomed Pharmacother"},{"key":"9046_CR70","first-page":"13","volume":"15","author":"GH Sun","year":"2024","unstructured":"Sun GH, Wang B, Wu XY et al (2024) How do sphingosine-1-phosphate affect immune cells to resolve inflammation? Front Immunol 15:13","journal-title":"Front Immunol"},{"key":"9046_CR71","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.4049\/jimmunol.171.7.3500","volume":"171","author":"G Dorsam","year":"2003","unstructured":"Dorsam G, Graeler MH, Seroogy C, Kong Y, Voice JK, Goetzl EJ (2003) Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J Immunol 171:3500\u20133507","journal-title":"J Immunol"},{"key":"9046_CR72","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.4049\/jimmunol.178.8.4885","volume":"178","author":"WG Wang","year":"2007","unstructured":"Wang WG, Huang MC, Goetzl EJ (2007) Type I sphingosine 1-phosphate G protein-coupled receptor (SIP1) mediation of enhanced IL-4 generation by CD4 T cells from SIP1 transgenic mice. J Immunol 178:4885\u20134890","journal-title":"J Immunol"},{"key":"9046_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2019.01409","volume":"10","author":"L Xiao","year":"2019","unstructured":"Xiao L, Zhou YH, Friis T, Beagley K, Xiao Y (2019) S1P\u2013S1PR1 signaling: the \u201csphinx\u201d in osteoimmunology. Front Immunol 10:18","journal-title":"Front Immunol"},{"key":"9046_CR74","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147:728\u2013741","journal-title":"Cell"},{"key":"9046_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13075-017-1385-y","volume":"19","author":"C Alessandri","year":"2017","unstructured":"Alessandri C, Ciccia F, Priori R et al (2017) CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjogren\u2019s syndrome patients and correlates with focus score and disease activity. Arthritis Res Ther 19:11","journal-title":"Arthritis Res Ther"},{"key":"9046_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fphar.2022.860146","volume":"13","author":"J Jeong","year":"2022","unstructured":"Jeong J, Choi YJ, Lee HK (2022) The role of autophagy in the function of CD4+ T cells and the development of chronic inflammatory diseases. Front Pharmacol 13:15","journal-title":"Front Pharmacol"},{"key":"9046_CR77","first-page":"13","volume":"15","author":"XX Zhao","year":"2024","unstructured":"Zhao XX, Ma D, Yang BQ, Wang YJ, Zhang LY (2024) Research progress of T cell autophagy in autoimmune diseases. Front Immunol 15:13","journal-title":"Front Immunol"},{"key":"9046_CR78","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/eji.201646375","volume":"46","author":"J van Loosdregt","year":"2016","unstructured":"van Loosdregt J, Rossetti M, Spreafico R et al (2016) Increased autophagy in CD4+ T cells of rheumatoid arthritis patients results in T-cell hyperactivation and apoptosis resistance. Eur J Immunol 46:2862\u20132870","journal-title":"Eur J Immunol"},{"key":"9046_CR79","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","volume":"99","author":"A Calcinotto","year":"2019","unstructured":"Calcinotto A, Kohli J, Zagato E, Pellegrini L, Demaria M, Alimonti A (2019) Cellular senescence: aging, cancer, and injury. Physiol Rev 99:1047\u20131078","journal-title":"Physiol Rev"},{"key":"9046_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2016\/8426874","volume":"2016","author":"SJ Xia","year":"2016","unstructured":"Xia SJ, Zhang XY, Zheng SB et al (2016) An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res 2016:12","journal-title":"J Immunol Res"},{"key":"9046_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.0105-2896.2005.00256.x","volume":"205","author":"AN Vallejo","year":"2005","unstructured":"Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158\u2013169","journal-title":"Immunol Rev"},{"key":"9046_CR82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2004.01.002","volume":"10","author":"AN Vallejo","year":"2004","unstructured":"Vallejo AN, Weyand CM, Goronzy JJ (2004) T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 10:119\u2013124","journal-title":"Trends Mol Med"},{"key":"9046_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/cei.12245","volume":"176","author":"G Kumar","year":"2014","unstructured":"Kumar G, Roger PM, Ticchioni M et al (2014) T cells from chronic bone infection show reduced proliferation and a high proportion of CD28- CD4 T cells. Clin Exp Immunol 176:49\u201357","journal-title":"Clin Exp Immunol"},{"key":"9046_CR84","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00264-014-2310-5","volume":"38","author":"U Dapunt","year":"2014","unstructured":"Dapunt U, Giese T, Prior B, Gaida MM, H\u00e4nsch GM (2014) Infectious versus non-infectious loosening of implants: activation of T lymphocytes differentiates between the two entities. Int Orthop 38:1291\u20131296","journal-title":"Int Orthop"},{"key":"9046_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fimmu.2018.00095","volume":"9","author":"J Fessler","year":"2018","unstructured":"Fessler J, Husic R, Schwetz V et al (2018) Senescent T-cell promote bone loss in rheumatoid arthritis. Front Immunol 9:9","journal-title":"Front Immunol"},{"key":"9046_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/sji.12139","volume":"79","author":"J Pieper","year":"2014","unstructured":"Pieper J, Johansson S, Snir O et al (2014) Peripheral and site-specific CD4+ CD28 null T cells from rheumatoid arthritis patients show distinct characteristics. Scand J Immunol 79:149\u2013155","journal-title":"Scand J Immunol"},{"key":"9046_CR87","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molimm.2020.04.003","volume":"122","author":"W Phoksawat","year":"2020","unstructured":"Phoksawat W, Jumnainsong A, Sornkayasit K, Srisak K, Komanasin N, Leelayuwat C (2020) IL-17 and IFN-\u03b3 productions by CD4+T cells and T cell subsets expressing NKG2D associated with the Number of risk factors for cardiovascular diseases. Mol Immunol 122:193\u2013199","journal-title":"Mol Immunol"},{"key":"9046_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0021216","volume":"6","author":"AM Tyagi","year":"2011","unstructured":"Tyagi AM, Srivastava K, Sharan K, Yadav D, Maurya R, Singh D (2011) Daidzein prevents the increase in CD4+ CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS ONE 6:10","journal-title":"PLoS ONE"},{"key":"9046_CR89","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1073\/pnas.86.14.5257","volume":"86","author":"DE Cool","year":"1989","unstructured":"Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG (1989) cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci U S A 86:5257\u20135261","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR90","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ni.2246","volume":"13","author":"I Rhee","year":"2012","unstructured":"Rhee I, Veillette A (2012) Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol 13:439\u2013447","journal-title":"Nat Immunol"},{"key":"9046_CR91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","volume":"123","author":"V Fischer","year":"2022","unstructured":"Fischer V, Haffner-Luntzer M (2022) Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol 123:14\u201321","journal-title":"Semin Cell Dev Biol"},{"key":"9046_CR92","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/art.39256","volume":"67","author":"B Aradi","year":"2015","unstructured":"Aradi B, Kato M, Filkova M et al (2015) Protein tyrosine phosphatase nonreceptor type 2 an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol 67:2624\u20132633","journal-title":"Arthritis Rheumatol"},{"key":"9046_CR93","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1172\/JCI123267","volume":"129","author":"MND Svensson","year":"2019","unstructured":"Svensson MND, Doody KM, Schmiedel BJ et al (2019) Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity. J Clin Invest 129:1193\u20131210","journal-title":"J Clin Invest"},{"key":"9046_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fcell.2021.788680","volume":"9","author":"Y Sun","year":"2021","unstructured":"Sun Y, Li JB, Xie XP et al (2021) Recent advances in osteoclast biological behavior. Front Cell Dev Biol 9:19","journal-title":"Front Cell Dev Biol"},{"key":"9046_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ijms21165685","volume":"21","author":"J Kodama","year":"2020","unstructured":"Kodama J, Kaito T (2020) Osteoclast multinucleation: review of current literature. Int J Mol Sci 21:31","journal-title":"Int J Mol Sci"},{"key":"9046_CR96","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev.bioeng.8.061505.095721","volume":"8","author":"AG Robling","year":"2006","unstructured":"Robling AG, Castillo AB, Turner CH (2006) Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8:455\u2013498","journal-title":"Annu Rev Biomed Eng"},{"key":"9046_CR97","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cells9092073","volume":"9","author":"JM Kim","year":"2020","unstructured":"Kim JM, Lin CJ, Stavre Z, Greenblatt MB, Shim JH (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells 9:14","journal-title":"Cells"},{"key":"9046_CR98","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Hayashi M, Fukunaga T et al (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231\u20131234","journal-title":"Nat Med"},{"key":"9046_CR99","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"9046_CR100","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/brv.12302","volume":"92","author":"JD Currey","year":"2017","unstructured":"Currey JD, Dean MN, Shahar R (2017) Revisiting the links between bone remodelling and osteocytes: insights from across phyla. Biol Rev 92:1702\u20131719","journal-title":"Biol Rev"},{"key":"9046_CR101","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","volume":"21","author":"HM Torres","year":"2023","unstructured":"Torres HM, Arnold KM, Oviedo M, Westendorf JJ, Weaver SR (2023) Inflammatory processes affecting bone health and repair. Curr Osteoporos Rep 21:842\u2013853","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR102","first-page":"1642","volume":"136","author":"N Hu","year":"2023","unstructured":"Hu N, Wang J, Ju BM et al (2023) Osteoimmunology research in rheumatoid arthritis: from single-cell omics approach. Chin Med J 136:1642\u20131652","journal-title":"Chin Med J"},{"key":"9046_CR103","first-page":"14","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zheng YL, Wang R, Wang XQ, Zhang H (2022) Exercise for osteoporosis: a literature review of pathology and mechanism. Front Immunol 13:14","journal-title":"Front Immunol"},{"key":"9046_CR104","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/jbmr.2868","volume":"31","author":"L Ib\u00e1\u00f1ez","year":"2016","unstructured":"Ib\u00e1\u00f1ez L, Abou-Ezzi G, Ciucci T et al (2016) Inflammatory osteoclasts prime TNF\u03b1-producing CD4+ T cells and express CX3CR1. J Bone Miner Res 31:1899\u20131908","journal-title":"J Bone Miner Res"},{"key":"9046_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.intimp.2022.108998","volume":"110","author":"Q Xu","year":"2022","unstructured":"Xu Q, Li D, Chen J et al (2022) Crosstalk between the gut microbiota and postmenopausal osteoporosis: mechanisms and applications. Int Immunopharmacol 110:13","journal-title":"Int Immunopharmacol"},{"key":"9046_CR106","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI115588","volume":"89","author":"J Chow","year":"1992","unstructured":"Chow J, Tobias JH, Colston KW, Chambers TJ (1992) Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Investig 89:74\u201378","journal-title":"J Clin Investig"},{"key":"9046_CR107","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA-J Am Med Assoc 292:490\u2013495","journal-title":"JAMA-J Am Med Assoc"},{"key":"9046_CR108","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MED.0b013e3282fe6ca9","volume":"15","author":"D Vanderschueren","year":"2008","unstructured":"Vanderschueren D, Gaytant J, Boonen S, Venken K (2008) Androgens and bone. Curr Opin Endocrinol Diabetes Obes 15:250\u2013254","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"9046_CR109","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/med.22081","volume":"45","author":"Y Yao","year":"2025","unstructured":"Yao Y, Cai XY, Chen Y, Zhang M, Zheng CH (2025) Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis. Med Res Rev 45:561\u2013575","journal-title":"Med Res Rev"},{"key":"9046_CR110","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186\u20131194","journal-title":"J Clin Invest"},{"key":"9046_CR111","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1359\/jbmr.060726","volume":"21","author":"SK Lee","year":"2006","unstructured":"Lee SK, Kadono Y, Okada F et al (2006) T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21:1704\u20131712","journal-title":"J Bone Miner Res"},{"key":"9046_CR112","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/jbmr.3966","volume":"35","author":"A Cline-Smith","year":"2020","unstructured":"Cline-Smith A, Axelbaum A, Shashkova E et al (2020) Ovariectomy activates chronic low-grade inflammation mediated by memory T cells, which promotes osteoporosis in mice. J Bone Miner Res 35:1174\u20131187","journal-title":"J Bone Miner Res"},{"key":"9046_CR113","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","volume":"23","author":"S Khosla","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23:576\u2013581","journal-title":"Trends Endocrinol Metab"},{"key":"9046_CR114","first-page":"10","volume":"13","author":"XN Wang","year":"2022","unstructured":"Wang XN, Zhang X, Han YD et al (2022) Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis. Front Endocrinol 13:10","journal-title":"Front Endocrinol"},{"key":"9046_CR115","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000443531","volume":"68","author":"RQ Zhao","year":"2016","unstructured":"Zhao RQ, Wang XZ, Feng FF (2016) Upregulated cellular expression of IL-17 by CD4+T-cells in osteoporotic postmenopausal women. Ann Nutr Metab 68:113\u2013118","journal-title":"Ann Nutr Metab"},{"key":"9046_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/09513590.2014.975683","volume":"31","author":"J Zhang","year":"2015","unstructured":"Zhang J, Fu Q, Ren ZZ et al (2015) Changes of serum cytokines-related Th1\/Th2\/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol Endocrinol 31:183\u2013190","journal-title":"Gynecol Endocrinol"},{"key":"9046_CR117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41598-021-95640-0","volume":"11","author":"H Bhadricha","year":"2021","unstructured":"Bhadricha H, Patel V, Singh AK et al (2021) Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep 11:10","journal-title":"Sci Rep"},{"key":"9046_CR118","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00198-013-2548-6","volume":"25","author":"I Moln\u00e1r","year":"2014","unstructured":"Moln\u00e1r I, Bohaty I, Somogyin\u00e9-V\u00e1ri \u00c9 (2014) IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis. Osteoporosis Int 25:783\u2013786","journal-title":"Osteoporosis Int"},{"key":"9046_CR119","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/jbmr.2228","volume":"29","author":"AM Tyagi","year":"2014","unstructured":"Tyagi AM, Mansoori MN, Srivastava K et al (2014) Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-\u03b1 antibodies. J Bone Miner Res 29:1981\u20131992","journal-title":"J Bone Miner Res"},{"key":"9046_CR120","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1096\/fj.202200911R","volume":"37","author":"MP Zhu","year":"2023","unstructured":"Zhu MP, Guo Q, Kang HL et al (2023) Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathway. Faseb J 37:22","journal-title":"Faseb J"},{"key":"9046_CR121","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41419-024-06475-2","volume":"15","author":"RP Peng","year":"2024","unstructured":"Peng RP, Dong YM, Zheng M et al (2024) IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. Cell Death Dis 15:12","journal-title":"Cell Death Dis"},{"key":"9046_CR122","first-page":"23","volume":"11","author":"ZQ Yao","year":"2022","unstructured":"Yao ZQ, Getting SJ, Locke IC (2022) Regulation of TNF-induced osteoclast differentiation. Cells 11:23","journal-title":"Cells"},{"key":"9046_CR123","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S8756-3282(00)00457-9","volume":"28","author":"RL van Bezooijen","year":"2001","unstructured":"van Bezooijen RL, Papapoulos SE, L\u00f6wik C (2001) Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-\u03baB and receptor activator of nuclear factor \u03baB (RANK)\/RANK ligand signaling? Bone 28:378\u2013386","journal-title":"Bone"},{"key":"9046_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.intimp.2022.108631","volume":"107","author":"JH Zhong","year":"2022","unstructured":"Zhong JH, Wang ZX, Yuan WL, Shen YQ, Chen LL (2022) Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo. Int Immunopharmacol 107:12","journal-title":"Int Immunopharmacol"},{"key":"9046_CR125","first-page":"13","volume":"18","author":"H Tang","year":"2023","unstructured":"Tang H, Zhu SD, Chen K, Yuan SJ, Hu JZ, Wang HK (2023) IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK\/mTOR\/Beclin1 pathway. PLoS ONE 18:13","journal-title":"PLoS ONE"},{"key":"9046_CR126","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481\u20131488","journal-title":"J Clin Invest"},{"key":"9046_CR127","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"BH Zhao","year":"2017","unstructured":"Zhao BH (2017) TNF and bone remodeling. Curr Osteoporos Rep 15:126\u2013134","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR128","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2020.117921","volume":"256","author":"IA Uehara","year":"2020","unstructured":"Uehara IA, Soldi LR, Silva MJB (2020) Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines. Life Sci 256:8","journal-title":"Life Sci"},{"key":"9046_CR129","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/cei.13271","volume":"196","author":"K Oi","year":"2019","unstructured":"Oi K, Tokunaga T, Kuranobu T et al (2019) Tumour necrosis factor \u03b1 augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression. Clin Exp Immunol 196:392\u2013402","journal-title":"Clin Exp Immunol"},{"key":"9046_CR130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms21010349","volume":"21","author":"A Qadir","year":"2020","unstructured":"Qadir A, Liang SJ, Wu ZX, Chen ZH, Hu LF, Qian AR (2020) Senile osteoporosis: the involvement of differentiation and senescence of bone marrow stromal cells. Int J Mol Sci 21:23","journal-title":"Int J Mol Sci"},{"key":"9046_CR131","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms23052701","volume":"23","author":"U F\u00f6ger-Samwald","year":"2022","unstructured":"F\u00f6ger-Samwald U, Kerschan-Schindl K, Butylina M, Pietschmann P (2022) Age related osteoporosis: targeting cellular senescence. Int J Mol Sci 23:15","journal-title":"Int J Mol Sci"},{"key":"9046_CR132","doi-asserted-by":"crossref","unstructured":"Carrasco E, de las Heras MMG, Gaband\u00e9-Rodr\u00edguez E, Desd\u00edn-Mic\u00f3 G, Aranda JF, Mittelbrunn M (2022) The role of T cells in age-related diseases. Nat Rev Immunol 22:97\u2013111","DOI":"10.1038\/s41577-021-00557-4"},{"key":"9046_CR133","doi-asserted-by":"publisher","first-page":"100 -+","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh MJ, Flores RR, Zhu Y et al (2021) An aged immune system drives senescence and ageing of solid organs. Nature 594:100-+","journal-title":"Nature"},{"key":"9046_CR134","doi-asserted-by":"publisher","first-page":"1371 -+","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3 G, Soto-Heredero G, Aranda JF et al (2020) T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368:1371-+","journal-title":"Science"},{"key":"9046_CR135","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00011-006-6034-x","volume":"55","author":"M De Martinis","year":"2006","unstructured":"De Martinis M, Di Benedetto MC, Mengoli LP, Ginaldi L (2006) Senile osteoporosis: is it an immune-mediated disease? Inflamm Res 55:399\u2013404","journal-title":"Inflamm Res"},{"key":"9046_CR136","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-022-01227-0","volume":"8","author":"ZQ Liu","year":"2023","unstructured":"Liu ZQ, Liang QM, Ren YQ et al (2023) Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther 8:16","journal-title":"Signal Transduct Target Ther"},{"key":"9046_CR137","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","volume":"16","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey EV (2020) Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 16:437\u2013447","journal-title":"Nat Rev Endocrinol"},{"key":"9046_CR138","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.03.002","volume":"70","author":"M Chen","year":"2023","unstructured":"Chen M, Fu WY, Xu HY, Liu CJ (2023) Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev 70:54\u201366","journal-title":"Cytokine Growth Factor Rev"},{"key":"9046_CR139","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2005-0717","volume":"147","author":"C Swanson","year":"2006","unstructured":"Swanson C, Lorentzon M, Conaway HH, Lerner UH (2006) Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-\u03baB (NF-\u03baB) ligand, osteoprotegerin, and receptor activator of NF-\u03baB in mouse calvarial bones. Endocrinology 147:3613\u20133622","journal-title":"Endocrinology"},{"key":"9046_CR140","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/endo.139.3.5778","volume":"139","author":"J Rubin","year":"1998","unstructured":"Rubin J, Biskobing DM, Jadhav L et al (1998) Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology 139:1006\u20131012","journal-title":"Endocrinology"},{"key":"9046_CR141","first-page":"18","volume":"11","author":"M Aur\u00e9al","year":"2021","unstructured":"Aur\u00e9al M, Machuca-Gayet I, Coury F (2021) Rheumatoid arthritis in the view of osteoimmunology. Biomolecules 11:18","journal-title":"Biomolecules"},{"key":"9046_CR142","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms23158740","volume":"23","author":"P Pietschmann","year":"2022","unstructured":"Pietschmann P, Butylina M, Kerschan-Schindl K, Sipos W (2022) Mechanisms of systemic osteoporosis in rheumatoid arthritis. Int J Mol Sci 23:14","journal-title":"Int J Mol Sci"},{"key":"9046_CR143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41598-017-00052-8","volume":"7","author":"SF Li","year":"2017","unstructured":"Li SF, Yin H, Zhang KN et al (2017) Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity. Sci Rep 7:11","journal-title":"Sci Rep"},{"key":"9046_CR144","first-page":"12","volume":"7","author":"Z Chen","year":"2016","unstructured":"Chen Z, Andreev D, Oeser K et al (2016) Th2 and eosinophil responses suppress inflammatory arthritis. Nat Commun 7:12","journal-title":"Nat Commun"},{"key":"9046_CR145","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/jcb.26370","volume":"119","author":"WG Wang","year":"2018","unstructured":"Wang WG, Li MJ, Luo M et al (2018) Naringenin inhibits osteoclastogenesis through modulation of helper T cells-secreted IL-4. J Cell Biochem 119:2084\u20132093","journal-title":"J Cell Biochem"},{"key":"9046_CR146","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.33347","volume":"64","author":"T Karonitsch","year":"2012","unstructured":"Karonitsch T, von Dalwigk K, Steiner CW et al (2012) Interferon signals and monocytic sensitization of the interferon-? signaling pathway in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 64:400\u2013408","journal-title":"Arthritis Rheum"},{"key":"9046_CR147","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.23372","volume":"58","author":"HB Kwak","year":"2008","unstructured":"Kwak HB, Ha H, Kim HN et al (2008) Reciprocal cross-talk between RANKL and interferon-\u03b3-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum 58:1332\u20131342","journal-title":"Arthritis Rheum"},{"key":"9046_CR148","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.4049\/jimmunol.0900072","volume":"183","author":"JD Ji","year":"2009","unstructured":"Ji JD, Park-Min KH, Shen ZX et al (2009) Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-\u03b3 in human osteoclast precursors. J Immunol 183:7223\u20137233","journal-title":"J Immunol"},{"key":"9046_CR149","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J (2018) Regulation of osteoclast differentiation by cytokine networks. Immune Network 18:18","journal-title":"Immune Network"},{"key":"9046_CR150","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jbspin.2015.07.010","volume":"83","author":"Q Xiong","year":"2016","unstructured":"Xiong Q, Zhang LH, Ge W, Tang PF (2016) The roles of interferons in osteoclasts and osteoclastogenesis. Joint Bone Spine 83:276\u2013281","journal-title":"Joint Bone Spine"},{"key":"9046_CR151","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/jir.2011.0019","volume":"32","author":"J Cheng","year":"2012","unstructured":"Cheng J, Liu JZ, Shi ZQ et al (2012) Molecular mechanisms of the biphasic effects of interferon-\u03b3 on osteoclastogenesis. J Interferon Cytokine Res 32:34\u201345","journal-title":"J Interferon Cytokine Res"},{"key":"9046_CR152","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.imlet.2011.02.017","volume":"137","author":"H Kohara","year":"2011","unstructured":"Kohara H, Kitaura H, Fujimura Y et al (2011) IFN-\u03b3 directly inhibits TNF-\u03b1-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas\/Fas ligand interactions. Immunol Lett 137:53\u201361","journal-title":"Immunol Lett"},{"key":"9046_CR153","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota K, Yoshitomi H, Hashimoto M et al (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204:2803\u20132812","journal-title":"J Exp Med"},{"key":"9046_CR154","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74:5\u201317","journal-title":"Cytokine"},{"key":"9046_CR155","doi-asserted-by":"publisher","first-page":"62 -+","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu N, Okamoto K, Sawa S et al (2014) Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med 20:62-+","journal-title":"Nat Med"},{"key":"9046_CR156","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00774-018-0965-5","volume":"37","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y (2019) Clinical immunity in bone and joints. J Bone Miner Metab 37:2\u20138","journal-title":"J Bone Miner Metab"},{"key":"9046_CR157","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaut.2009.10.003","volume":"34","author":"LM Charbonnier","year":"2010","unstructured":"Charbonnier LM, Han WGH, Quentin J et al (2010) Adoptive transfer of IL-10-secreting CD4+ CD49b+ regulatory T cells suppresses ongoing arthritis. J Autoimmun 34:390\u2013399","journal-title":"J Autoimmun"},{"key":"9046_CR158","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu12102999","volume":"12","author":"J Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz J, Akhavan NS, Mullins AP, Arjmandi BH (2020) Macrophage polarization and osteoporosis: a review. Nutrients 12:16","journal-title":"Nutrients"},{"key":"9046_CR159","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2021.108784","volume":"229","author":"EP von Kaeppler","year":"2021","unstructured":"von Kaeppler EP, Wang Q, Raghu H, Bloom MS, Wong HD, Robinson WH (2021) Interleukin 4 promotes anti-inflammatory macrophages that clear cartilage debris and inhibits osteoclast development to protect against osteoarthritis. Clin Immunol 229:10","journal-title":"Clin Immunol"},{"key":"9046_CR160","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/jbm.a.37142","volume":"109","author":"J Pajarinen","year":"2021","unstructured":"Pajarinen J, Lin TH, Nabeshima A et al (2021) Interleukin-4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover. J Biomed Mater Res Part A 109:1512\u20131520","journal-title":"J Biomed Mater Res Part A"},{"key":"9046_CR161","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.14336\/AD.2021.0110","volume":"12","author":"L Gonz\u00e1lez-Osuna","year":"2021","unstructured":"Gonz\u00e1lez-Osuna L, Sierra-Cristancho A, Rojas C et al (2021) Premature senescence of T-cells favors bone loss during osteolytic diseases. A new concern in the osteoimmunology arena. Aging Dis 12:1150\u20131161","journal-title":"Aging Dis"},{"key":"9046_CR162","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F (2021) Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17:387\u2013404","journal-title":"Nat Rev Rheumatol"},{"key":"9046_CR163","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11882-014-0489-6","volume":"15","author":"JA Smith","year":"2015","unstructured":"Smith JA (2015) Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep 15:9","journal-title":"Curr Allergy Asthma Rep"},{"key":"9046_CR164","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-017-1480-0","volume":"19","author":"A Deminger","year":"2017","unstructured":"Deminger A, Klingberg E, Lorentzon M et al (2017) Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study. Arthritis Res Ther 19:12","journal-title":"Arthritis Res Ther"},{"key":"9046_CR165","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1002\/jcp.30313","volume":"236","author":"LF Liu","year":"2021","unstructured":"Liu LF, Yuan Y, Zhang SH, Xu JK, Zou J (2021) Osteoimmunological insights into the pathogenesis of ankylosing spondylitis. J Cell Physiol 236:6090\u20136100","journal-title":"J Cell Physiol"},{"key":"9046_CR166","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10067-015-2961-7","volume":"34","author":"SK Raychaudhuri","year":"2015","unstructured":"Raychaudhuri SK, Saxena A, Raychaudhuri SP (2015) Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol 34:1019\u20131023","journal-title":"Clin Rheumatol"},{"key":"9046_CR167","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","volume":"14","author":"EM Gravallese","year":"2018","unstructured":"Gravallese EM, Schett G (2018) Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat Rev Rheumatol 14:631\u2013640","journal-title":"Nat Rev Rheumatol"},{"key":"9046_CR168","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13075-019-1948-1","volume":"21","author":"C Klasen","year":"2019","unstructured":"Klasen C, Meyer A, Wittekind PS, Waqu\u00e9 I, Nabhani S, Kofler DM (2019) Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis. Arthritis Res Ther 21:13","journal-title":"Arthritis Res Ther"},{"key":"9046_CR169","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2016.01171","volume":"11","author":"ZL Duan","year":"2017","unstructured":"Duan ZL, Gui YY, Li C et al (2017) The immune dysfunction in ankylosing spondylitis patients. BioSci Trends 11:69\u201376","journal-title":"BioSci Trends"},{"key":"9046_CR170","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16:380\u2013390","journal-title":"Nat Rev Rheumatol"},{"key":"9046_CR171","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1530\/EC-23-0040","volume":"12","author":"R Xu","year":"2023","unstructured":"Xu R, Lian DF, Xie Y et al (2023) Relationship between serum uric acid levels and osteoporosis. Endocr Connect 12:8","journal-title":"Endocr Connect"},{"key":"9046_CR172","first-page":"15","volume":"15","author":"MJ Kwon","year":"2023","unstructured":"Kwon MJ, Park JY, Kim SG et al (2023) Potential association of osteoporosis and not osteoporotic fractures in patients with gout: a longitudinal follow-up study. Nutrients 15:15","journal-title":"Nutrients"},{"key":"9046_CR173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/nu11092111","volume":"11","author":"KM Lin","year":"2019","unstructured":"Lin KM, Lu CL, Hung KC et al (2019) The paradoxical role of uric acid in osteoporosis. Nutrients 11:17","journal-title":"Nutrients"},{"key":"9046_CR174","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.intimp.2020.106877","volume":"88","author":"B Wang","year":"2020","unstructured":"Wang B, Chen SJ, Qian HY et al (2020) Role of T cells in the pathogenesis and treatment of gout. Int Immunopharmacol 88:7","journal-title":"Int Immunopharmacol"},{"key":"9046_CR175","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MAJ.0b013e31817727af","volume":"337","author":"R Webb","year":"2009","unstructured":"Webb R, Jeffries M, Sawalha AH (2009) Uric acid directly promotes human T-cell activation. Am J Med Sci 337:23\u201327","journal-title":"Am J Med Sci"},{"key":"9046_CR176","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.4049\/jimmunol.172.9.5734","volume":"172","author":"M Jaramillo","year":"2004","unstructured":"Jaramillo M, Naccache PH, Olivier M (2004) Monosodium urate crystals synergize with IFN-\u03b3 to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1\/2 and NF-\u03baB. J Immunol 172:5734\u20135742","journal-title":"J Immunol"},{"key":"9046_CR177","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bbrc.2018.02.166","volume":"497","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhao QZ, Yin YX, McNutt MA, Zhang T, Cao YT (2018) Serum levels of IL-17 are elevated in patients with acute gouty arthritis. Biochem Biophys Res Commun 497:897\u2013902","journal-title":"Biochem Biophys Res Commun"},{"key":"9046_CR178","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/jci.insight.171417","volume":"8","author":"HJ Yu","year":"2023","unstructured":"Yu HJ, Xue W, Yu HQ et al (2023) Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission. JCI Insight 8:18","journal-title":"JCI Insight"},{"key":"9046_CR179","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2019.104351","volume":"147","author":"F Raucci","year":"2019","unstructured":"Raucci F, Iqbal AJ, Saviano A et al (2019) IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation. Pharmacol Res 147:10","journal-title":"Pharmacol Res"},{"key":"9046_CR180","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s10753-018-0839-y","volume":"41","author":"XJ Dai","year":"2018","unstructured":"Dai XJ, Tao JH, Fang X et al (2018) Changes of Treg\/Th17 ratio in spleen of acute gouty arthritis rat induced by MSU crystals. Inflammation 41:1955\u20131964","journal-title":"Inflammation"},{"key":"9046_CR181","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/ar3483","volume":"13","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Nam KI, Jin HM et al (2011) Bone destruction by receptor activator of nuclear factor \u03baB ligand-expressing T cells in chronic gouty arthritis. Arthritis Res Ther 13:12","journal-title":"Arthritis Res Ther"},{"key":"9046_CR182","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/0192623317735316","volume":"45","author":"MN Weitzmann","year":"2017","unstructured":"Weitzmann MN (2017) Bone and the immune system. Toxicol Pathol 45:911\u2013924","journal-title":"Toxicol Pathol"},{"key":"9046_CR183","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V et al (2014) Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 28:1193\u20131202","journal-title":"AIDS"},{"key":"9046_CR184","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/COH.0000000000000269","volume":"11","author":"E Alvarez","year":"2016","unstructured":"Alvarez E, Belloso WH, Boyd MA et al (2016) Which HIV patients should be screened for osteoporosis: an international perspective. Curr Opin HIV AIDS 11:268\u2013276","journal-title":"Curr Opin HIV AIDS"},{"key":"9046_CR185","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165\u20132174","journal-title":"AIDS"},{"key":"9046_CR186","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.1093\/infdis\/jis199","volume":"205","author":"VW Harris","year":"2012","unstructured":"Harris VW, Brown TT (2012) Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis 205:S391\u2013S398","journal-title":"J Infect Dis"},{"key":"9046_CR187","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-011-0099-z","volume":"9","author":"I Ofotokun","year":"2012","unstructured":"Ofotokun I, McIntosh E, Weitzmann MN (2012) HIV: inflammation and bone. Curr Hiv\/Aids Rep 9:16\u201325","journal-title":"Curr Hiv\/Aids Rep"},{"key":"9046_CR188","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fendo.2020.00502","volume":"11","author":"MV Delpino","year":"2020","unstructured":"Delpino MV, Quarleri J (2020) Influence of HIV infection and antiretroviral therapy on bone homeostasis. Front Endocrinol 11:9","journal-title":"Front Endocrinol"},{"key":"9046_CR189","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1479-5876-11-51","volume":"11","author":"L Gazzola","year":"2013","unstructured":"Gazzola L, Bellistri GM, Tincati C et al (2013) Association between peripheral T-lymphocyte activation and impaired bone mineral density in HIV-infected patients. J Transl Med 11:10","journal-title":"J Transl Med"},{"key":"9046_CR190","doi-asserted-by":"crossref","unstructured":"Kwak MK, Lee EJ, Park JW et al (2019) CD4 T cell count is positively associated with lumbar spine bone mass in HIV-infected men under the age of 50 years (vol 30, pg 1501, 2019). Osteoporosis Int 30:2363\u20132363","DOI":"10.1007\/s00198-019-05115-2"},{"key":"9046_CR191","doi-asserted-by":"publisher","first-page":"13848","DOI":"10.1073\/pnas.1003020107","volume":"107","author":"T Vikulina","year":"2010","unstructured":"Vikulina T, Fan XA, Yamaguchi M et al (2010) Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A 107:13848\u201313853","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9046_CR192","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1371\/journal.ppat.1004497","volume":"10","author":"K Titanji","year":"2014","unstructured":"Titanji K, Vunnava A, Sheth AN et al (2014) Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathog 10:14","journal-title":"PLoS Pathog"},{"key":"9046_CR193","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/QAD.0000000000001764","volume":"32","author":"K Titanji","year":"2018","unstructured":"Titanji K, Vunnava A, Foster A et al (2018) T-cell receptor activator of nuclear factor-\u03baB ligand\/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts. AIDS 32:885\u2013894","journal-title":"AIDS"},{"key":"9046_CR194","first-page":"12","volume":"13","author":"T Li","year":"2022","unstructured":"Li T, Hadigan C, Whitlock JM et al (2022) IL-27 modulates the cytokine secretion in the T cell-osteoclast crosstalk during HIV infection. Front Immunol 13:12","journal-title":"Front Immunol"},{"key":"9046_CR195","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/COH.0000000000000692","volume":"16","author":"S Shukla","year":"2021","unstructured":"Shukla S, Kumari S, Bal SK et al (2021) \u201cGo\u201d, \u201cNo Go,\u201d or \u201cWhere to Go\u201d; does microbiota dictate T cell exhaustion, programming, and HIV persistence? Curr Opin HIV AIDS 16:215\u2013222","journal-title":"Curr Opin HIV AIDS"},{"key":"9046_CR196","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","volume":"43","author":"L Men\u00e9ndez-Arias","year":"2022","unstructured":"Men\u00e9ndez-Arias L, Delgado R (2022) Update and latest advances in antiretroviral therapy. Trends Pharmacol Sci 43:16\u201329","journal-title":"Trends Pharmacol Sci"},{"key":"9046_CR197","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","volume":"23","author":"B Grund","year":"2009","unstructured":"Grund B, Peng G, Gibert CL et al (2009) Continuous antiretroviral therapy decreases bone mineral density. AIDS 23:1519\u20131529","journal-title":"AIDS"},{"key":"9046_CR198","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00223-022-00946-4","volume":"110","author":"E Biver","year":"2022","unstructured":"Biver E (2022) Osteoporosis and HIV infection. Calcif Tissue Int 110:624\u2013640","journal-title":"Calcif Tissue Int"},{"key":"9046_CR199","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/cid\/cit538","volume":"57","author":"PM Grant","year":"2013","unstructured":"Grant PM, Kitch D, McComsey GA et al (2013) Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis 57:1483\u20131488","journal-title":"Clin Infect Dis"},{"key":"9046_CR200","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/infdis\/jix444","volume":"216","author":"MN Weitzmann","year":"2017","unstructured":"Weitzmann MN, Vikulina T, Roser-Page S, Yamaguchi M, Ofotokun I (2017) Homeostatlc expansion of CD4+ T cells promotes cortical and trabecular bone loss, whereas CD8+ T cells induce trabecular bone loss only. J Infect Dis 216:1070\u20131079","journal-title":"J Infect Dis"},{"key":"9046_CR201","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ncomms9282","volume":"6","author":"I Ofotokun","year":"2015","unstructured":"Ofotokun I, Titanji K, Vikulina T et al (2015) Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nat Commun 6:15","journal-title":"Nat Commun"},{"key":"9046_CR202","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/infdis\/jiab631","volume":"226","author":"MN Weitzmann","year":"2022","unstructured":"Weitzmann MN, Weiss D, Vikulina T et al (2022) Immune reconstitution bone loss exacerbates bone degeneration due to natural aging in a mouse model. J Infect Dis 226:38\u201348","journal-title":"J Infect Dis"},{"key":"9046_CR203","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joim.12873","volume":"285","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon M (2019) Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med 285:381\u2013394","journal-title":"J Intern Med"},{"key":"9046_CR204","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/OGX.0000000000001181","volume":"78","author":"E Rentzeperi","year":"2023","unstructured":"Rentzeperi E, Pegiou S, Tsakiridis I et al (2023) Diagnosis and management of osteoporosis: a comprehensive review of guidelines. Obstet Gynecol Surv 78:657\u2013681","journal-title":"Obstet Gynecol Surv"},{"key":"9046_CR205","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10787-015-0233-4","volume":"23","author":"RM Talaat","year":"2015","unstructured":"Talaat RM, Sidek A, Mosalem A, Kholief A (2015) Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis. Inflammopharmacology 23:119\u2013125","journal-title":"Inflammopharmacology"},{"key":"9046_CR206","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"9046_CR207","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11914-016-0331-2","volume":"22","author":"D Bellavia","year":"2024","unstructured":"Bellavia D, Costa V, De Luca A et al (2024) Vitamin D Level between calcium-phosphorus homeostasis and immune system: new perspective in osteoporosis. Curr Osteoporos Rep 22:599\u2013610","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR208","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/infdis\/jit355","volume":"208","author":"M Olliver","year":"2013","unstructured":"Olliver M, Spelmink L, Hiew J, Meyer-Hoffert U, Henriques-Normark B, Bergman P (2013) Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. J Infect Dis 208:1474\u20131481","journal-title":"J Infect Dis"},{"key":"9046_CR209","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MD.0000000000023739","volume":"99","author":"LY Zhang","year":"2020","unstructured":"Zhang LY, Cao ZY, Yang YY, Tan XY, Mao JC, Su L (2020) Traditional Chinese medicine on treating active rheumatoid arthritis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 99:4","journal-title":"Medicine (Baltimore)"},{"key":"9046_CR210","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3109\/13880209.2014.884606","volume":"52","author":"E Mukwaya","year":"2014","unstructured":"Mukwaya E, Xu F, Wong MS, Zhang Y (2014) Chinese herbal medicine for bone health. Pharm Biol 52:1223\u20131228","journal-title":"Pharm Biol"},{"key":"9046_CR211","first-page":"28","volume":"15","author":"XX Wang","year":"2024","unstructured":"Wang XX, Sun B, Wang YJ et al (2024) Research progress of targeted therapy regulating Th17\/Treg balance in bone immune diseases. Front Immunol 15:28","journal-title":"Front Immunol"},{"key":"9046_CR212","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2023.1077796","volume":"14","author":"Y Jiao","year":"2023","unstructured":"Jiao Y, Wang X, Wang Q et al (2023) Mechanisms by which kidney-tonifying Chinese herbs inhibit osteoclastogenesis: emphasis on immune cells. Front Pharmacol 14:14","journal-title":"Front Pharmacol"},{"key":"9046_CR213","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1359\/jbmr.070207","volume":"22","author":"N Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of TNF-\u03b1 and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724\u2013729","journal-title":"J Bone Miner Res"},{"key":"9046_CR214","doi-asserted-by":"crossref","unstructured":"Corrado A, Neve A, Maruotti N, Cantatore FP (2013) Bone effects of biologic drugs in rheumatoid arthritis. Clin Dev Immunol 2013:945945","DOI":"10.1155\/2013\/945945"},{"key":"9046_CR215","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/acr.23233","volume":"69","author":"H Marzo-Ortega","year":"2017","unstructured":"Marzo-Ortega H, Sieper J, Kivitz A et al (2017) Secukinumab and sustained improvement in signs and symptoms of patients with active ankylosing spondylitis through two years: results from a phase III study. Arthritis Care Res 69:1020\u20131029","journal-title":"Arthritis Care Res"},{"key":"9046_CR216","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/OARRR.S265806","volume":"12","author":"H Tahir","year":"2020","unstructured":"Tahir H, Moorthy A, Chan A (2020) Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives. Open Access Rheumatol 12:277\u2013292","journal-title":"Open Access Rheumatol"},{"key":"9046_CR217","first-page":"239","volume":"20","author":"M Abu-Shakra","year":"2018","unstructured":"Abu-Shakra M, Zisman D, Balbir-Gurman A et al (2018) Effect of tocilizumab on fatigue and bone mineral density in patients with rheumatoid arthritis. Isr Med Assoc J 20:239\u2013244","journal-title":"Isr Med Assoc J"},{"key":"9046_CR218","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/rheumatology\/ket468","volume":"53","author":"K Kume","year":"2014","unstructured":"Kume K, Amano K, Yamada S et al (2014) The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis. Rheumatology 53:900\u2013903","journal-title":"Rheumatology"},{"key":"9046_CR219","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/annrheumdis-2018-214894","volume":"78","author":"S Finzel","year":"2019","unstructured":"Finzel S, Kraus S, Figueiredo CP et al (2019) Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis. Ann Rheum Dis 78:1186\u20131191","journal-title":"Ann Rheum Dis"},{"key":"9046_CR220","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1172\/JCI86062","volume":"126","author":"JY Li","year":"2016","unstructured":"Li JY, Chassaing B, Tyagi AM et al (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126:2049\u20132063","journal-title":"J Clin Invest"},{"key":"9046_CR221","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fphar.2022.1042189","volume":"13","author":"S Rastogi","year":"2022","unstructured":"Rastogi S, Singh A (2022) Gut microbiome and human health: exploring how the probiotic genus Lactobacillus modulate immune responses. Front Pharmacol 13:17","journal-title":"Front Pharmacol"},{"key":"9046_CR222","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2021.680073","volume":"12","author":"ZX Fan","year":"2021","unstructured":"Fan ZX, Ross RP, Stanton C et al (2021) Lactobacillus casei CCFM1074 Alleviates Collagen-Induced Arthritis in Rats via Balancing Treg\/Th17 and Modulating the Metabolites and Gut Microbiota. Front Immunol 12:15","journal-title":"Front Immunol"},{"key":"9046_CR223","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41598-020-80536-2","volume":"11","author":"L Sapra","year":"2021","unstructured":"Sapra L, Dar HY, Bhardwaj A et al (2021) Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Sci Rep 11:18","journal-title":"Sci Rep"},{"key":"9046_CR224","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2022.875788","volume":"13","author":"L Sapra","year":"2022","unstructured":"Sapra L, Shokeen N, Porwal K et al (2022) Bifidobacterium longum Ameliorates Ovariectomy-Induced Bone Loss via Enhancing Anti-Osteoclastogenic and Immunomodulatory Potential of Regulatory B Cells (Bregs). Front Immunol 13:19","journal-title":"Front Immunol"},{"key":"9046_CR225","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijbiomac.2024.134655","volume":"278","author":"S Yadav","year":"2024","unstructured":"Yadav S, Sapra L, Srivastava RK (2024) Polysaccharides to postbiotics: Nurturing bone health via modulating \u201cgut-immune axis.\u201d Int J Biol Macromol 278:17","journal-title":"Int J Biol Macromol"},{"key":"9046_CR226","doi-asserted-by":"publisher","first-page":"212 -+","DOI":"10.1016\/j.immuni.2018.12.015","volume":"50","author":"GJ Britton","year":"2019","unstructured":"Britton GJ, Contijoch EJ, Mogno I et al (2019) Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and ROR\u03b3t+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity 50:212-+","journal-title":"Immunity"},{"key":"9046_CR227","doi-asserted-by":"publisher","first-page":"228 -+","DOI":"10.1038\/nature23475","volume":"548","author":"T Xu","year":"2017","unstructured":"Xu T, Stewart KM, Wang XH et al (2017) Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548:228-+","journal-title":"Nature"},{"key":"9046_CR228","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/nano13040692","volume":"13","author":"JY Wen","year":"2023","unstructured":"Wen JY, Cai DL, Gao WD et al (2023) Osteoimmunomodulatory Nanoparticles for Bone Regeneration. Nanomaterials 13:21","journal-title":"Nanomaterials"},{"key":"9046_CR229","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40824-023-00413-7","volume":"27","author":"AP Dayanandan","year":"2023","unstructured":"Dayanandan AP, Cho WJ, Kang H et al (2023) Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomater Res 27:25","journal-title":"Biomater Res"},{"issue":"94","key":"9046_CR230","first-page":"9","volume":"2024","author":"RJ Miron","year":"2000","unstructured":"Miron RJ, Bohner M, Zhang YF, Bosshardt DD (2000) Osteoinduction and osteoimmunology: Emerging concepts. Periodontol 2024(94):9\u201326","journal-title":"Periodontol"},{"key":"9046_CR231","first-page":"12","volume":"2015","author":"JB Zhang","year":"2015","unstructured":"Zhang JB, Liu XR, Deng TM et al (2015) Development of drug loaded nanoparticles binding to hydroxyapatite based on a bisphosphonate modified nonionic surfactant. J Nanomater 2015:12","journal-title":"J Nanomater"},{"key":"9046_CR232","first-page":"3150","volume":"6","author":"XS Yang","year":"2021","unstructured":"Yang XS, Zhou FX, Yuan PY et al (2021) T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg\/Th17 balance. Bioact Mater 6:3150\u20133163","journal-title":"Bioact Mater"},{"key":"9046_CR233","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/nano13152183","volume":"13","author":"L Casarrubios","year":"2023","unstructured":"Casarrubios L, Cicu\u00e9ndez M, Vallet-Reg\u00ed M, Portol\u00e9s MT, Arcos D, Feito MJ (2023) Osteoimmune properties of mesoporous bioactive nanospheres: a study on t helper lymphocytes. Nanomaterials 13:17","journal-title":"Nanomaterials"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09046-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:02:26Z","timestamp":1744297346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09046-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":233,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9046"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09046-1","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"22 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"41"}}